TAK-875
GPR40激动剂；(3S)-6-[[2',6'-二甲基-4'-[3-(甲磺酰基)丙氧基][1,1'-联苯]-3-基]甲氧基]-2,3-二氢-3-苯并呋喃乙酸
(+)-TAK 875
GPR40激动剂；(3S)-6-[[2',6'-二甲基-4'-[3-(甲磺酰基)丙氧基][1,1'-联苯]-3-基]甲氧基]-2,3-二氢-3-苯并呋喃乙酸
(+)-TAK 875
-
产品编号： CTR004915
-
CAS号： 1000413-72-8
-
分子式：C29H32O7S
-
分子量：524.63
英文别名：
(3S)-6-[[2',6'-Dimethyl-4'-[3-(methylsulfonyl)propoxy][1,1'-biphenyl]-3-yl]methoxy]-2,3-dihydro-3-benzofuranacetic Acid
SMILES：
CC(CCCC(C1CCC2C(=CCCC12C)/C=C/C1CC(O)CCC=1C)C)C
参考文献：
Arak, T., et al.: Diabetes. Obesity. Metabolism., 14, 271 (2012); De Lartigue, J., Drugs of the Future., 36, 813 (2011);
Burant, C.F.,et al.: Lancet., 379, 1403 (2012);
TAK-876 is a selective G protein-coupled receptor 40 (GPR40) agonist. TAK-876 is a novel oral medication that has been developed to improve the secretion of insulin in a glucose-dependent manner, which has the potential to improve the control of blood sug
搜索质检报告(COA)
搜索MSDS
